Fosun Pharmaceutical Secures Clinical Trial Approval for Colorectal Cancer Treatment

MT NewswiresFeb 27 23:07 ET

Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Investors Are Sitting on a Loss of 39% If They Invested Three Years Ago

Simply Wall StFeb 27 19:58 ET

FOSUN PHARMA (02196.HK) holding subsidiary has obtained approval for pharmaceutical clinical trials.

On February 27, Gelonghui reported that FOSUN PHARMA (02196.HK) announced that its holding subsidiary, Jiangsu Xingsheng Xinhui Pharmaceutical Co., Ltd. (hereinafter referred to as 'Xingsheng Xinhui'), recently received approval from the National Medical Products Administration for the clinical trial of XS-03 tablets (application registration category: Chemical medicine Class 1; hereinafter referred to as 'XS-03') in combination with FOLFOX or FOLFIRI and Bevacizumab for the treatment of RAS mutated metastatic colorectal cancer (hereinafter referred to as 'the treatment scheme'). Xingsheng Xinhui intends to conduct the Ib/II clinical trial for the treatment scheme in mainland China (excluding Hong Kong, Macau, and Taiwan) when conditions are favorable.

Gelonghui FinanceFeb 27 05:39 ET

Express News | Shanghai Fosun Pharma - Received Approval From Nmpa for Clinical Trial of Xs-03 Tablets

ReutersFeb 27 05:37 ET

Fosun Pharmaceutical Gets Marketing Authorization for Chronic Kidney Disease Drug

MT NewswiresFeb 26 22:58 ET

The wave of AI in Medical is sweeping: the potential of the macromolecule new drug market is highlighted and imaging products are "going overseas" into Emerging Markets | Focus

① Some executives from pharmaceutical companies have stated that "currently, the discovery of small molecule drugs is very challenging; finding potential molecules and structures is already quite difficult, while there is still significant potential in the discovery and design of large molecule new drugs." ② Currently, the application maturity of AI technology in the imaging field is relatively high, and relevant manufacturers have revealed that the market potential for AI imaging large models in Belt and Road Initiative Concept countries is quite extensive.

cls.cnFeb 26 20:37 ET